Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Friedmann

Showing results (141-150 of 223) with videos related to

Pageof 23
Sort By:
The Diabetes Educator|December 8, 2009
Pharmacist-led group medical appointment model in type 2 diabetesTracey H Taveira, Peter D Friedmann, Lisa B Cohen, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 7, 2012
In vitro coagulation effects of ophthalmic doses of bevacizumabEmily Li, Paul B Greenberg, Victoria Tseng, et al.
Pain Medicine (Malden, Mass.)|August 1, 2012
How does use of a prescription monitoring program change medical practice?Traci C Green, Marita R Mann, Sarah E Bowman, et al.
Substance Abuse Treatment, Prevention, and Policy|March 19, 2013
The index of tobacco treatment quality: development of a tool to assess evidence-based treatment in a national sample of drug treatment facilitiesA Paula Cupertino, Jamie J Hunt, Byron J Gajewski, et al.
Drug and Alcohol Dependence|December 7, 2018
Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usualWilliam E Soares, Donna Wilson, Michael S Gordon, et al.
Ophthalmology|November 2, 2010
Prevalence and predictors of ocular complications associated with cataract surgery in United States veteransPaul B Greenberg, Victoria L Tseng, Wen-Chih Wu, et al.
JAMA Network Open|September 24, 2024
Factors Associated With the Availability of Medications for Opioid Use Disorder in US JailsElizabeth Flanagan Balawajder, Lori Ducharme, Bruce G Taylor, et al.
JAMA Network Open|April 16, 2025
Barriers to Universal Availability of Medications for Opioid Use Disorder in US JailsElizabeth Flanagan Balawajder, Lori Ducharme, Bruce G Taylor, et al.
Ophthalmology|March 11, 2011
Cataract surgery complications in nonagenariansVictoria L Tseng, Paul B Greenberg, Wen-Chih Wu, et al.
Journal of the American Pharmacists Association : Japha|May 24, 2013
How does use of a prescription monitoring program change pharmacy practice?Traci C Green, Marita R Mann, Sarah E Bowman, et al.
Pageof 23

Showing results (141-150 of 223) with videos related to

Sort By:
Pageof 23
The Diabetes Educator|December 8, 2009
Pharmacist-led group medical appointment model in type 2 diabetesTracey H Taveira, Peter D Friedmann, Lisa B Cohen, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|February 7, 2012
In vitro coagulation effects of ophthalmic doses of bevacizumabEmily Li, Paul B Greenberg, Victoria Tseng, et al.
Pain Medicine (Malden, Mass.)|August 1, 2012
How does use of a prescription monitoring program change medical practice?Traci C Green, Marita R Mann, Sarah E Bowman, et al.
Substance Abuse Treatment, Prevention, and Policy|March 19, 2013
The index of tobacco treatment quality: development of a tool to assess evidence-based treatment in a national sample of drug treatment facilitiesA Paula Cupertino, Jamie J Hunt, Byron J Gajewski, et al.
Drug and Alcohol Dependence|December 7, 2018
Incidence of future arrests in adults involved in the criminal justice system with opioid use disorder receiving extended release naltrexone compared to treatment as usualWilliam E Soares, Donna Wilson, Michael S Gordon, et al.
Ophthalmology|November 2, 2010
Prevalence and predictors of ocular complications associated with cataract surgery in United States veteransPaul B Greenberg, Victoria L Tseng, Wen-Chih Wu, et al.
JAMA Network Open|September 24, 2024
Factors Associated With the Availability of Medications for Opioid Use Disorder in US JailsElizabeth Flanagan Balawajder, Lori Ducharme, Bruce G Taylor, et al.
JAMA Network Open|April 16, 2025
Barriers to Universal Availability of Medications for Opioid Use Disorder in US JailsElizabeth Flanagan Balawajder, Lori Ducharme, Bruce G Taylor, et al.
Ophthalmology|March 11, 2011
Cataract surgery complications in nonagenariansVictoria L Tseng, Paul B Greenberg, Wen-Chih Wu, et al.
Journal of the American Pharmacists Association : Japha|May 24, 2013
How does use of a prescription monitoring program change pharmacy practice?Traci C Green, Marita R Mann, Sarah E Bowman, et al.
Pageof 23